Related Experiment Videos
Relative afferent pupillary defects in optic neuritis
American Journal of Ophthalmology
|November 1, 1981
Summary
Relative afferent pupillary defects are common in optic neuritis patients. Careful testing reveals these visual pathway abnormalities in nearly all unilateral and most bilateral cases, aiding diagnosis.
Area of Science:
- Ophthalmology
- Neuro-ophthalmology
- Optic Nerve Diseases
Background:
- Optic neuritis is an inflammatory condition affecting the optic nerve.
- Relative afferent pupillary defect (RAPD) is a key clinical sign of optic nerve dysfunction.
- Accurate detection of RAPD is crucial for diagnosing and monitoring optic neuritis.
Purpose of the Study:
- To quantify the prevalence of relative afferent pupillary defects (RAPDs) in patients with optic neuritis.
- To assess the diagnostic utility of RAPD testing across different stages and forms of optic neuritis.
- To investigate the association between RAPD and subclinical optic neuropathy in the fellow eye.
Main Methods:
- Prospective measurement of relative afferent pupillary defects (RAPDs) using a swinging flashlight test.
- Inclusion of 105 patients with various stages of optic neuritis (acute unilateral, recovered unilateral, acute bilateral, recovered bilateral).
- Correlation of RAPD findings with clinical presentation and, where applicable, visual-evoked potential (VEP) results.
Main Results:
- RAPDs were detected in 96% of acute unilateral optic neuritis cases.
- Prevalence of RAPDs was 92% in recovered unilateral cases and 91.7% in acute cases with contralateral optic neuropathy.
- RAPDs were found in 65.8% of recovered bilateral cases, highlighting the sensitivity of the test.
Conclusions:
- Relative afferent pupillary defects are highly prevalent in unilateral optic neuritis, present in nearly all patients.
- RAPD testing is a valuable tool for detecting optic nerve dysfunction in both acute and recovered stages of optic neuritis.
- Absence of RAPD in suspected unilateral optic neuritis warrants further investigation, such as VEPs, to rule out subclinical disease in the other eye.